PRUDENTIAL FINANCIAL INC - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 273 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2019. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRUDENTIAL FINANCIAL INC ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2023$234,634
-82.8%
69,010
-62.9%
0.00%
-100.0%
Q2 2023$1,367,387
+25.2%
186,039
+76.5%
0.00%0.0%
Q1 2023$1,091,913
-79.9%
105,397
-77.1%
0.00%
-77.8%
Q4 2022$5,443,655
-25.3%
460,936
+32.7%
0.01%
-25.0%
Q3 2022$7,291,000
+24.8%
347,372
+81.6%
0.01%
+33.3%
Q2 2022$5,842,000
-13.0%
191,335
+17.0%
0.01%0.0%
Q1 2022$6,714,000
-48.7%
163,507
-34.3%
0.01%
-43.8%
Q4 2021$13,087,000
+2.1%
248,765
-2.7%
0.02%
-11.1%
Q3 2021$12,812,000
-44.9%
255,782
-30.7%
0.02%
-43.8%
Q2 2021$23,246,000
-11.1%
369,047
+31.2%
0.03%
-17.9%
Q1 2021$26,141,000
-22.4%
281,363
-25.1%
0.04%
-31.6%
Q4 2020$33,676,000
-1.8%
375,848
+13.2%
0.06%
-10.9%
Q3 2020$34,298,000
+56.5%
331,912
+19.8%
0.06%
+52.4%
Q2 2020$21,911,000
+23.4%
277,083
-9.7%
0.04%
+7.7%
Q1 2020$17,760,000
-10.7%
306,945
-16.7%
0.04%
+34.5%
Q4 2019$19,877,000
+69.1%
368,413
+63.8%
0.03%
+52.6%
Q3 2019$11,758,000
-32.3%
224,907
-37.4%
0.02%
-29.6%
Q2 2019$17,363,000
+2.6%
359,408
+7.3%
0.03%
-3.6%
Q1 2019$16,920,000
-6.4%
334,937
+9.8%
0.03%
-12.5%
Q4 2018$18,086,000
-18.4%
305,089
-9.4%
0.03%
-3.0%
Q3 2018$22,156,000
+142.6%
336,560
+86.1%
0.03%
+135.7%
Q2 2018$9,133,000
-58.4%
180,888
-56.6%
0.01%
-57.6%
Q1 2018$21,951,000
+518.7%
416,921
+446.1%
0.03%
+560.0%
Q4 2017$3,548,000
+16.4%
76,343
+1.3%
0.01%
+25.0%
Q3 2017$3,049,000
+23.6%
75,378
+3.6%
0.00%0.0%
Q2 2017$2,467,000
-1.4%
72,760
-15.5%
0.00%0.0%
Q1 2017$2,501,000
-38.6%
86,146
-30.6%
0.00%
-42.9%
Q4 2016$4,075,000
-49.6%
124,077
-51.6%
0.01%
-46.2%
Q3 2016$8,080,000
+14.9%
256,250
+2.4%
0.01%
+8.3%
Q2 2016$7,035,000
+4.3%
250,167
+34.9%
0.01%0.0%
Q1 2016$6,743,000
-9.5%
185,497
-0.4%
0.01%
-7.7%
Q4 2015$7,448,000
+61.1%
186,154
+14.7%
0.01%
+44.4%
Q3 2015$4,623,000
-28.3%
162,254
-17.1%
0.01%
-18.2%
Q2 2015$6,447,000
+238.1%
195,654
+195.1%
0.01%
+266.7%
Q1 2015$1,907,000
+7.4%
66,294
+1.7%
0.00%0.0%
Q4 2014$1,775,000
+26.9%
65,194
-0.7%
0.00%0.0%
Q3 2014$1,399,000
-42.6%
65,634
-39.5%
0.00%
-25.0%
Q2 2014$2,439,000
-69.3%
108,575
-65.5%
0.00%
-73.3%
Q1 2014$7,954,000
+58.4%
314,749
+44.1%
0.02%
+50.0%
Q4 2013$5,020,000
+38.7%
218,349
+14.9%
0.01%
+25.0%
Q3 2013$3,620,000
+85.1%
190,049
+40.1%
0.01%
+100.0%
Q2 2013$1,956,000135,6490.00%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Zebra Capital Management LLC 20,591$895,0001.43%
Global Alpha Capital Management Ltd. 330,270$14,357,0001.39%
AIMZ Investment Advisors, LLC 73,875$3,211,0001.25%
Hillcrest Asset Management LLC 184,010$7,999,0001.22%
Bridge City Capital, LLC 56,869$2,472,0001.02%
SNYDER CAPITAL MANAGEMENT L P 683,700$29,720,0000.72%
EARNEST PARTNERS LLC 2,188,606$95,139,0000.55%
RICE HALL JAMES & ASSOCIATES, LLC 343,347$14,925,0000.53%
PALISADE CAPITAL MANAGEMENT, LP 584,957$25,428,0000.52%
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 45,693$1,986,0000.45%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders